Geode Capital Management
ACER

Geode Capital Management’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-136,955
Closed -$113K 4767
2023
Q3
$113K Buy
136,955
+40,625
+42% +$33.5K ﹤0.01% 4205
2023
Q2
$89K Hold
96,330
﹤0.01% 4372
2023
Q1
$73.1K Hold
96,330
﹤0.01% 4434
2022
Q4
$241K Buy
96,330
+5,515
+6% +$13.8K ﹤0.01% 3998
2022
Q3
$126K Hold
90,815
﹤0.01% 4454
2022
Q2
$114K Buy
90,815
+6,644
+8% +$8.34K ﹤0.01% 4541
2022
Q1
$244K Sell
84,171
-590
-0.7% -$1.71K ﹤0.01% 4283
2021
Q4
$194K Buy
84,761
+20,737
+32% +$47.5K ﹤0.01% 4489
2021
Q3
$163K Buy
64,024
+6,415
+11% +$16.3K ﹤0.01% 4520
2021
Q2
$164K Buy
57,609
+16,111
+39% +$45.9K ﹤0.01% 4412
2021
Q1
$129K Sell
41,498
-231
-0.6% -$718 ﹤0.01% 4243
2020
Q4
$109K Hold
41,729
﹤0.01% 4045
2020
Q3
$120K Hold
41,729
﹤0.01% 3859
2020
Q2
$143K Sell
41,729
-20,035
-32% -$68.7K ﹤0.01% 3763
2020
Q1
$122K Sell
61,764
-13,989
-18% -$27.6K ﹤0.01% 3701
2019
Q4
$303K Buy
75,753
+1,268
+2% +$5.07K ﹤0.01% 3674
2019
Q3
$237K Buy
74,485
+9,239
+14% +$29.4K ﹤0.01% 3710
2019
Q2
$254K Buy
65,246
+29,510
+83% +$115K ﹤0.01% 3721
2019
Q1
$868K Hold
35,736
﹤0.01% 3219
2018
Q4
$719K Buy
35,736
+4,297
+14% +$86.5K ﹤0.01% 3239
2018
Q3
$969K Buy
+31,439
New +$969K ﹤0.01% 3234
2017
Q3
Sell
-35,913
Closed -$23K 4079
2017
Q2
$23K Hold
35,913
﹤0.01% 4035
2017
Q1
$27K Hold
35,913
﹤0.01% 4022
2016
Q4
$33K Hold
35,913
﹤0.01% 3963
2016
Q3
$115K Hold
35,913
﹤0.01% 3775
2016
Q2
$148K Hold
35,913
﹤0.01% 3685
2016
Q1
$83 Hold
35,913
﹤0.01% 3879
2015
Q4
$99K Hold
35,913
﹤0.01% 3886
2015
Q3
$112K Sell
35,913
-251,403
-88% -$784K ﹤0.01% 3870
2015
Q2
$127K Buy
287,316
+213,303
+288% +$94.3K ﹤0.01% 3722
2015
Q1
$40K Hold
74,013
﹤0.01% 3874
2014
Q4
$53K Hold
74,013
﹤0.01% 3868
2014
Q3
$73K Hold
74,013
﹤0.01% 3800
2014
Q2
$122K Hold
74,013
﹤0.01% 3654
2014
Q1
$136K Hold
74,013
﹤0.01% 3599
2013
Q4
$134K Buy
74,013
+59,968
+427% +$109K ﹤0.01% 3535
2013
Q3
$31K Hold
14,045
﹤0.01% 3620
2013
Q2
$21K Buy
+14,045
New +$21K ﹤0.01% 3589